Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading

AD CME Group Education AD Bank of England Statistics AD Investing.com Markets AD LSEG Data
City & Markets

Arcturus Therapeutics Announces Third Quarter 2026 Financial Results and Pipeline Progress

City noticeboard, Trade Hub UK (2026-11-06): Arcturus Therapeutics Holdings Inc. reported its financial results for the third quarter ended September 30, 2026. Revenue was $18.3 million and $23.3 million… Primary source: original at Nasdaq (nasdaq.com).

Arcturus Therapeutics Announces Third Quarter 2026 Financial Results and Pipeline Progress

Arcturus Therapeutics Holdings Inc. reported its financial results for the third quarter ended September 30, 2026. Revenue was $18.3 million and $23.3 million for the three and nine months ended September 30, 2026, respectively, compared with $17.2 million and $74.8 million in th

Read at source